The American Psychiatric Association Publishing Textbook of Schizophrenia, 2nd Edition

Αγαπημένα

Αγαπημένα

The new edition of The
American Psychiatric Association Publishing Textbook of
Schizophrenia plumbs the current state of knowledge about the disorder’s
origin, nature, and treatment in a comprehensive, authoritative, and thoroughly
revised text. Schizophrenia is one of the leading causes of disability
worldwide and remains among the most challenging and disheartening disorders
confronting psychiatrists and other mental health care providers because of its
profound effects on patient functioning, its onset just as young adults are
launching their lives, and the limitations of current pharmacological
treatments. Designed to bring the reader up to date on the latest research,
this new edition represents a complete overhaul of the previous text, with a
new structure, new chapters, and new contributors. Subjects such as genetics
and neurobiology, distinguished by rapid advancements in knowledge, are
explored in depth, as are new models of service delivery and psychosocial
treatments that are making a significant difference in patients’ lives.
Foundational information on the epidemiology, etiology, and psychopathology of
the illness is presented clearly and cogently, emphasizing research conducted
over the last decade. Theories regarding the pathophysiological basis of the
disorder, including genetic, molecular, and neurocircuitry models, are examined
in detail.

Other
noteworthy topics include:

• Cultural variations, examining how culture
  influences the presentation of schizophrenia from the perspective of the
  experts in cultural psychiatry who developed the DSM-5 Cultural
  Formulation Interview


• Service delivery models, including assertive
  community treatment, critical time intervention, coordinated specialty
  care for early psychosis, and integrated dual diagnosis, informing
  clinicians about options for providing treatment to individuals with
  schizophrenia


• Advances in the existing pharmacological
  treatments, including use of adjunctive medications and combinations of
  antipsychotics, which, in the absence of new drug therapies, is
  indispensable knowledge


• A review of the promising field of
  neuromodulation


• Evaluation and treatment of comorbidities, such
  as depression, obsessive-compulsive disorder, and substance use disorders,
  vital information because over half of people with schizophrenia have at
  least one co-occurring behavioral health disorder


• Individual- and family-centered care, which
  presents the rationale and evidence for actively involving patients and
  family members in interventions and decision-making about treatments